Skip to main content
. 2023 Oct 27;15(21):5179. doi: 10.3390/cancers15215179
[18F]-FDG-PET [18]Fluorodeoxyglucose Positron Emission Tomography
CT Computed Tomography
ANZSNM Australian and New Zealand Society of Nuclear Medicine
CMR Complete Metabolic Response
EANM European Association of Nuclear Medicine
IO Immuno-oncology
irAE Immune-related Adverse Events
MATV Metabolic Activity Tumor Volume
PD-1 Programmed Death Protein/Ligand
PERCMIT PET Response Evaluation Criteria for Immunotherapy
RT Radiation Therapy
SNMMI Society of Nuclear Medicine and Molecular Imaging
SUV Standardized Uptake Value
TLG Total Lesion Glycolysis